Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin (Legalon) in Chronic Hepatitis C (SyNCH)
NCT00680342Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Apr 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silymarin in hepatitis C (HCV), sponsored by National Center for Complementary and Integrative Health. Started Apr 2008; status: completed.
02
Drugs
silymarin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00680342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680342.